A number of other equities research analysts have also recently issued reports on the stock. Royal Bank of Canada lowered their target price on shares of Veradigm from $22.00 to $11.00 and set an “outperform” rating on the stock in a report on Friday, January 19th. Barclays began coverage on shares of Veradigm in a report on Wednesday, January 3rd. They set an “equal weight” rating and a $11.00 target price on the stock. Finally, Stephens reissued an “equal weight” rating and set a $13.00 target price on shares of Veradigm in a report on Tuesday, November 14th. Four equities research analysts have rated the stock with a hold rating and one has issued a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average target price of $14.00.
Veradigm Trading Up 1.1 %
Institutional Inflows and Outflows
A number of institutional investors have recently added to or reduced their stakes in the company. TFO Wealth Partners LLC increased its stake in Veradigm by 105,280.0% in the fourth quarter. TFO Wealth Partners LLC now owns 5,269 shares of the software maker’s stock valued at $52,000 after acquiring an additional 5,264 shares during the last quarter. Allianz Asset Management GmbH increased its stake in Veradigm by 41.2% in the fourth quarter. Allianz Asset Management GmbH now owns 343,433 shares of the software maker’s stock valued at $3,603,000 after acquiring an additional 100,275 shares during the last quarter. Hsbc Holdings PLC bought a new position in Veradigm in the fourth quarter valued at $148,000. US Bancorp DE purchased a new stake in Veradigm during the fourth quarter valued at about $368,000. Finally, Aigen Investment Management LP purchased a new stake in Veradigm during the fourth quarter valued at about $231,000.
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
- Five stocks we like better than Veradigm
- What is a Dividend King?
- 3 attractive stocks that insiders are buying
- What Makes a Stock a Good Dividend Stock?
- Alpha and Omega Semiconductor ready to bounce, DOJ cloud lifts
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Wendy’s vs Shake Shack: Out with the new, in with the old?
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.